Big news with the Fosun Pharma partnership.


Also EMOR/Healixa filled an Annual Report today and two things stood out.

Todos deal was mentioned and still intact.

Amarantus & MANF, not one mention.

Seems like rather big omissions.
They say they have 68,305,686 n goodwill assets.
That's real close the the number they are supposed to pay AMBS in April.

Or, deal is off and MANF is back?

We will see once AMBS files.
https://www.otcmarkets.com/stock/EMOR/disclosure